Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease.
Papamichael, Konstantinos, Niels Vande Casteele, Bincy P Abraham, Timothy Ritter, Anjali Jain, and Adam S Cheifetz. 2023. “Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2978-2980.e2.